Fanouriakis, A., et al. (2023). EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases.

Use of biologics to treat moderate to severe systemic lupus erythematosus increased 45% between 2021 and 2023, according to recent findings from a market analysis conducted by Spherix Global ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

Lupus nephritis is considered an atypical presentation in late-onset SLE, but the investigators said it warrants aggressive management due to the risk of end-stage renal disease.

"SLE is a chronic and incurable auto-immune disease, which can cause multiple organ damages. The current treatment options are very limited," said Dr. Joan Shen , CEO of I-Mab .

Introduction. There is currently no known cure for systemic lupus erythematosus (SLE); therefore, the treatment of this chronic autoimmune disorder is focused on long-term management of disease ...